Phase II, Single-Arm Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer
Latest Information Update: 02 Aug 2024
At a glance
- Drugs Atezolizumab (Primary) ; Carboplatin (Primary) ; Cisplatin (Primary) ; Etoposide (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Acronyms Match
- Sponsors Roche
- 29 Jul 2024 Status changed from active, no longer recruiting to completed.
- 21 Dec 2023 Planned End Date changed from 30 Mar 2024 to 30 Jun 2024.
- 25 Sep 2023 Planned End Date changed from 2 Apr 2024 to 30 Mar 2024.